Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study

NCT05909215 is registered in ClinicalTrials.gov with Sindh Institute of Urology and Transplantation as lead sponsor.

NCT NCT05909215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05909215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study
Lead sponsor
Sindh Institute of Urology and Transplantation
Phase
Phase 4
Overall status
Completed
Start date
August 23, 2021
Completion date
December 13, 2021
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, hemodynamic instability, tracheal intubation